首页> 外文OA文献 >Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells

【2h】

Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells

机译：达沙替尼+吉非替尼，一种非铂类药物，具有增强的抑制人卵巢癌细胞生长，抑制迁移和抗侵袭能力

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Thibault, Benoît; Jean-Claude, Bertrand;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Dasatinib?+?Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells [J] . Beno?t Thibault, Bertrand Jean-Claude Journal of Ovarian Research . 2017,第1期

机译：达沙替尼+吉非替尼，一种非铂类药物，对人卵巢癌细胞具有增强的生长抑制，抗迁移和抗侵袭能力
2. Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells [J] . Anne Camirand, Mahvash Zakikhani, Fiona Young, Breast Cancer Research . 2005,第4期

机译：胰岛素样生长因子-1受体信号转导的抑制增强了吉非替尼（Iressa）在人乳腺癌细胞中的生长抑制和促凋亡作用
3. Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy. [J] . Giaccone G, Iacona RB, Fandi A, Journal of Cancer Research and Clinical Oncology . 2009,第3期

机译：未接受化疗的吉非替尼或安慰剂联合铂类化疗的未化疗的晚期非小细胞肺癌患者的表皮生长因子受体表达分析。
4. Fabrication of a β-TCP Nanomaterial and Its Inhibitory Effects on Human Ovarian Cancer SKOV-3 Cells [C] . Xiang Dong Ma, Xiao Ming Wu, Hai Xia Duan, International conference on material and manufacturing technology . 2010

机译：β-TCP纳米材料的制备及其对人卵巢癌SKOV-3细胞的抑制作用
5. Development of New Platinum-Based Anticancer Agents Targeting Ovarian Cancer Stem Cells [D] . ?Stilgenbauer, Morgan 2020

机译：新的铂类抗癌药物的发展目标定位卵巢癌干细胞
6. Dasatinib + Gefitinib a non platinum-based combination with enhanced growth inhibitory anti-migratory and anti-invasive potency against human ovarian cancer cells [O] . Benoît Thibault, Bertrand Jean-Claude 2017

机译：达沙替尼+吉非替尼一种非铂类药物具有增强的抑制人卵巢癌细胞生长抑制迁移和抗侵袭能力
7. Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells [O] . Thibault, Benoît, Jean-Claude, Bertrand 2016

机译：达沙替尼+吉非替尼，一种非铂类药物，具有增强的抑制人卵巢癌细胞生长，抑制迁移和抗侵袭能力
8. Cell Growth and Survival in Ovarian Epithelial Cancer Project 1: AKT2 Oncogene and Its Associated Protein APBP in Human Ovarian Cancer [R] . Nicosia, S. V. , Cheng, J. Q. 2003

机译：卵巢上皮癌细胞生长和存活项目1：人类卵巢癌中aKT2癌基因及其相关蛋白apBp

Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅